254 related articles for article (PubMed ID: 16968584)
21. Academic medical centers and conflicts of interest.
Ting JY
JAMA; 2006 Jun; 295(24):2846; author reply 2848-9. PubMed ID: 16804146
[No Abstract] [Full Text] [Related]
22. Managing perceived conflicts of interest while ensuring the continued innovation of medical technology.
Van Haute A
J Vasc Surg; 2011 Sep; 54(3 Suppl):31S-3S. PubMed ID: 21872113
[TBL] [Abstract][Full Text] [Related]
23. A perspective on commercial relationships between ophthalmology and industry.
Jampol LM; Packer S; Mills RP; Day SH; Lichter PR;
Arch Ophthalmol; 2009 Sep; 127(9):1194-202. PubMed ID: 19752430
[TBL] [Abstract][Full Text] [Related]
24. Fostering innovation without compromising integrity.
Pizzo PA
Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S10-1; discussion 16-22. PubMed ID: 17469467
[TBL] [Abstract][Full Text] [Related]
25. Ethics, industry, and outcomes.
Merry AF
Semin Cardiothorac Vasc Anesth; 2008 Mar; 12(1):7-11. PubMed ID: 18426846
[TBL] [Abstract][Full Text] [Related]
26. Clarifying conflict of interest.
Brody H
Am J Bioeth; 2011 Jan; 11(1):23-8. PubMed ID: 21240802
[TBL] [Abstract][Full Text] [Related]
27. Industry has undue influence on academic collaboration and safeguards need strengthening: white coat… which hat.
Harbin T
Surv Ophthalmol; 2014; 59(3):346-8. PubMed ID: 24508214
[No Abstract] [Full Text] [Related]
28. Conflict of interest and the Society for Vascular Surgery.
Elliott BM;
J Vasc Surg; 2011 Sep; 54(3 Suppl):3S-11S. PubMed ID: 21872107
[TBL] [Abstract][Full Text] [Related]
29. Conflict of interest in the physician interface with the biomedical industry.
Minnigan H; Chisholm CD
Emerg Med Clin North Am; 2006 Aug; 24(3):671-85. PubMed ID: 16877136
[TBL] [Abstract][Full Text] [Related]
30. A review of the federal guidelines that inform and influence relationships between physicians and industry.
Birkhahn RH; Jauch E; Kramer DA; Nowak RM; Raja AS; Summers RL; Weber JE; Diercks DB;
Acad Emerg Med; 2009 Aug; 16(8):776-81. PubMed ID: 19594459
[TBL] [Abstract][Full Text] [Related]
31. Too friendly? Teaching hospitals revisit ties to pharmaceutical firms.
Romano M
Mod Healthc; 2003 Jul; 33(28):17. PubMed ID: 12884711
[No Abstract] [Full Text] [Related]
32. Restrictions on interactions between doctors and industry could ultimately hurt patients.
Kimmelstiel C
J Vasc Surg; 2011 Sep; 54(3 Suppl):12S-4S. PubMed ID: 21872108
[TBL] [Abstract][Full Text] [Related]
33. Academic medical centers write their own rules.
Freischlag JA
J Vasc Surg; 2011 Sep; 54(3 Suppl):19S-21S. PubMed ID: 21872110
[TBL] [Abstract][Full Text] [Related]
34. From quid pro quo to quid pro bono: reshaping the influence of industry on health care epidemiologists.
Kirkland KB
Clin Infect Dis; 2010 Jan; 50(1):93-7. PubMed ID: 19951230
[TBL] [Abstract][Full Text] [Related]
35. Managing conflict of interest in clinical practice.
Camilleri M; Cortese DA
Mayo Clin Proc; 2007 May; 82(5):607-14. PubMed ID: 17493426
[TBL] [Abstract][Full Text] [Related]
36. Conflict of interest with industry and the challenges for surgical education.
Schwarze ML
J Am Coll Surg; 2009 Dec; 209(6):766-8. PubMed ID: 19959047
[No Abstract] [Full Text] [Related]
37. Conflict-of-interest management: efforts and insights from the Association of American Medical Colleges.
Kirch DG
Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S23-5; discussion S32-7. PubMed ID: 17471619
[TBL] [Abstract][Full Text] [Related]
38. Conflict of interest or productive collaboration? The pharma: academic relationship and its implications for headache medicine.
Finkel AG
Headache; 2006; 46(7):1181-5. PubMed ID: 16866722
[No Abstract] [Full Text] [Related]
39. Making research pay. Reaping rewards, conflicts for developing drugs.
Mantone J
Mod Healthc; 2006 Jun; 36(24):17-8. PubMed ID: 16792268
[No Abstract] [Full Text] [Related]
40. Cleveland Clinic talks conflicts. Critics worry new guidelines only address disclosure.
Romano M
Mod Healthc; 2006 May; 36(20):14. PubMed ID: 16752862
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
